CRISPR Therapeutics (CRSP) News Today $56.26 +0.37 (+0.65%) As of 01:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRSP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Bayforest Capital Ltd Makes New $423,000 Investment in CRISPR Therapeutics AG $CRSPSeptember 12 at 7:04 AM | marketbeat.comCRISPR Therapeutics AG (CRSP)’s Casgevy Expands Global Adoption in 2025September 11 at 7:38 PM | msn.comCathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190%September 11 at 3:45 AM | fool.comCRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025September 9 at 4:00 PM | globenewswire.comCRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9 at 12:08 PM | seekingalpha.comCRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 9 at 7:09 AM | seekingalpha.comRaymond James Financial Inc. Purchases 4,571 Shares of CRISPR Therapeutics AG $CRSPSeptember 9 at 3:16 AM | marketbeat.comTrexquant Investment LP Makes New $1.32 Million Investment in CRISPR Therapeutics AG $CRSPSeptember 8, 2025 | marketbeat.comAnalysts Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $71.60September 7, 2025 | americanbankingnews.comCRISPR Therapeutics AG (NASDAQ:CRSP) Receives Average Recommendation of "Hold" from BrokeragesSeptember 5, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Crispr Therapeutics AG (CRSP)September 4, 2025 | theglobeandmail.comCRISPR Therapeutics AG $CRSP Shares Sold by Baker BROS. Advisors LPSeptember 4, 2025 | marketbeat.comInvesco Ltd. Has $951,000 Holdings in CRISPR Therapeutics AG $CRSPSeptember 4, 2025 | marketbeat.comCathie Wood’s ARK ETF adjusts holdings, buys CRISPR and sells RokuSeptember 3, 2025 | investing.comCRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?September 3, 2025 | msn.comCRISPR Therapeutics to Participate in Upcoming Investor ConferencesSeptember 2, 2025 | globenewswire.comZacks Research Issues Optimistic Outlook for CRSP EarningsSeptember 2, 2025 | marketbeat.comOrbis Allan Gray Ltd Buys 86,813 Shares of CRISPR Therapeutics AG $CRSPSeptember 1, 2025 | marketbeat.comZacks Research Issues Positive Forecast for CRSP EarningsSeptember 1, 2025 | americanbankingnews.comRafferty Asset Management LLC Has $4.97 Million Stock Holdings in CRISPR Therapeutics AG $CRSPAugust 31, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Upgraded at Zacks ResearchAugust 30, 2025 | marketbeat.comCrispr Therapeutics AG (CRSP) Has a New Rating from Evercore ISIAugust 28, 2025 | theglobeandmail.comCresset Asset Management LLC Sells 4,771 Shares of CRISPR Therapeutics AG $CRSPAugust 28, 2025 | marketbeat.comCrispr Therapeutics: A Speculative Buy With Promising Potential AheadAugust 27, 2025 | seekingalpha.comVanguard Group Inc. Acquires 33,711 Shares of CRISPR Therapeutics AG $CRSPAugust 26, 2025 | marketbeat.comCathie Wood’s ARK Investment buys 189K shares of Crispr Therapeutics todayAugust 25, 2025 | msn.comCrispr Therapeutics: Sell Before It's Too LateAugust 25, 2025 | seekingalpha.comCRISPR Therapeutics (CRSP): Assessing Valuation Following Strong Casgevy Sales Growth and New Pipeline DataAugust 25, 2025 | finance.yahoo.comH.C. Wainwright Lifts CRISPR Therapeutics’ (CRSP) Price Target on CASGEVy Sales GrowthAugust 25, 2025 | finance.yahoo.comCRISPR Therapeutics AG $CRSP Shares Sold by T. Rowe Price Investment Management Inc.August 24, 2025 | marketbeat.comCRISPR Therapeutics AG $CRSP Stake Reduced by Charles Schwab Investment Management Inc.August 23, 2025 | marketbeat.comCRISPR Therapeutics (CRSP) Reports Increase In Q2 Revenue Despite Wider Net LossesAugust 22, 2025 | finance.yahoo.comBernstein Remains a Hold on Crispr Therapeutics AG (CRSP)August 20, 2025 | theglobeandmail.comCathie Wood’s ARK buys Robinhood, CRISPR, sells Genius Sports stockAugust 20, 2025 | investing.comFox Run Management L.L.C. Acquires New Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)August 19, 2025 | marketbeat.comWhat Makes Crispr Therapeutics Ag (CRSP) a Good Buy?August 18, 2025 | finance.yahoo.comEverSource Wealth Advisors LLC Buys 84,708 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)August 18, 2025 | marketbeat.comHere's How This Forgotten Healthcare Stock Could Generate Life-Changing ReturnsAugust 17, 2025 | fool.comCRISPR Therapeutics AG (NASDAQ:CRSP) Position Lessened by Vestmark Advisory Solutions Inc.August 17, 2025 | marketbeat.comIs CRISPR Therapeutics' (CRSP) Rising Net Loss a Sign of Bold Investment or Growing Pressure?August 16, 2025 | finance.yahoo.comVirtu Financial LLC Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP)August 15, 2025 | marketbeat.comUpgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025August 14, 2025 | seekingalpha.comBenjamin Edwards Inc. Grows Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)August 14, 2025 | marketbeat.comEquities Analysts Set Expectations for CRSP FY2026 EarningsAugust 12, 2025 | marketbeat.comHC Wainwright Has Positive Estimate for CRSP Q4 EarningsAugust 12, 2025 | marketbeat.comMarket Factors: Beware the high quality stock bubbleAugust 11, 2025 | theglobeandmail.comCrispr Therapeutics AG (CRSP) Gets a Buy from Truist FinancialAugust 10, 2025 | theglobeandmail.comBlair William & Co. IL Has $2.32 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)August 10, 2025 | marketbeat.comCetera Investment Advisers Has $1.97 Million Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)August 10, 2025 | marketbeat.comCrispr Therapeutics Faces Stock Dip Amid Promising DevelopmentsAugust 9, 2025 | msn.com Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRSP Media Mentions By Week CRSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.770.93▲Average Medical News Sentiment CRSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼1014▲CRSP Articles Average Week Get the Latest News and Ratings for CRSP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Allogene Therapeutics News Axsome Therapeutics News Beam Therapeutics News Editas Medicine News KALA BIO News Moderna News Intellia Therapeutics News Vertex Pharmaceuticals News Genmab A/S News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRSP Stock Alerts